IL2 and neoplasm: IL-2 can, however, also lead to CRS, which is associated with a higher number of CAR-T cells present.62 Furthermore, IL-2 also promotes the proliferation of the immunosuppressive regulatory T (Treg) cells,63 a phenomenon which hinders the anti-tumor efficacy of other immune cells.